180 related articles for article (PubMed ID: 24244422)
1. Downregulation of IFNG in CD4(+) T cells in lung cancer through hypermethylation: a possible mechanism of tumor-induced immunosuppression.
Wang F; Xu J; Zhu Q; Qin X; Cao Y; Lou J; Xu Y; Ke X; Li Q; Xie E; Zhang L; Sun R; Chen L; Fang B; Pan S
PLoS One; 2013; 8(11):e79064. PubMed ID: 24244422
[TBL] [Abstract][Full Text] [Related]
2. Non-small-cell lung cancer-induced immunosuppression by increased human regulatory T cells via Foxp3 promoter demethylation.
Ke X; Zhang S; Xu J; Liu G; Zhang L; Xie E; Gao L; Li D; Sun R; Wang F; Pan S
Cancer Immunol Immunother; 2016 May; 65(5):587-99. PubMed ID: 27000869
[TBL] [Abstract][Full Text] [Related]
3. CpG methylation of the IFNG gene as a mechanism to induce immunosuppression [correction of immunosupression] in tumor-infiltrating lymphocytes.
Janson PC; Marits P; Thörn M; Ohlsson R; Winqvist O
J Immunol; 2008 Aug; 181(4):2878-86. PubMed ID: 18684979
[TBL] [Abstract][Full Text] [Related]
4. Chronic exposure to trichloroethylene increases DNA methylation of the Ifng promoter in CD4
Gilbert KM; Blossom SJ; Erickson SW; Broadfoot B; West K; Bai S; Li J; Cooney CA
Toxicol Lett; 2016 Oct; 260():1-7. PubMed ID: 27553676
[TBL] [Abstract][Full Text] [Related]
5. Loss of methylation at the IFNG promoter and CNS-1 is associated with the development of functional IFN-γ memory in human CD4(+) T lymphocytes.
Dong J; Chang HD; Ivascu C; Qian Y; Rezai S; Okhrimenko A; Cosmi L; Maggi L; Eckhardt F; Wu P; Sieper J; Alexander T; Annunziato F; Gossen M; Li J; Radbruch A; Thiel A
Eur J Immunol; 2013 Mar; 43(3):793-804. PubMed ID: 23255246
[TBL] [Abstract][Full Text] [Related]
6. A tumor necrosis factor-alpha-inducible promoter variant of interferon-gamma accelerates CD4+ T cell depletion in human immunodeficiency virus-1-infected individuals.
An P; Vlahov D; Margolick JB; Phair J; O'Brien TR; Lautenberger J; O'Brien SJ; Winkler CA
J Infect Dis; 2003 Jul; 188(2):228-31. PubMed ID: 12854077
[TBL] [Abstract][Full Text] [Related]
7. Increased CD4
Ahlén Bergman E; Hartana CA; Johansson M; Linton LB; Berglund S; Hyllienmark M; Lundgren C; Holmström B; Palmqvist K; Hansson J; Alamdari F; Huge Y; Aljabery F; Riklund K; Winerdal ME; Krantz D; Zirakzadeh AA; Marits P; Sjöholm LK; Sherif A; Winqvist O
Clin Epigenetics; 2018 Aug; 10(1):102. PubMed ID: 30075815
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of Mycobacterium tuberculosis on interleukin-6 receptor 3'-untranslated region methylation in CD4
Mo SW; Zhu CZ; Liu XQ; Wan HQ; Li FX; Deng GF; Zhang ZD; Chen XC
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Apr; 45(4):379-386. PubMed ID: 35381636
[No Abstract] [Full Text] [Related]
9. Histone acetylation at the Ifng promoter in tolerized CD4 cells is associated with increased IFN-gamma expression during subsequent immunization to the same antigen.
Long M; Slaiby AM; Wu S; Hagymasi AT; Mihalyo MA; Bandyopadhyay S; Vella AT; Adler AJ
J Immunol; 2007 Nov; 179(9):5669-77. PubMed ID: 17947638
[TBL] [Abstract][Full Text] [Related]
10. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
11. Distinct Methylation of IFNG in the Gut.
Gonsky R; Deem RL; Targan SR
J Interferon Cytokine Res; 2009 Jul; 29(7):407-14. PubMed ID: 19450149
[TBL] [Abstract][Full Text] [Related]
12. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
13. Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14.
Cicchini L; Westrich JA; Xu T; Vermeer DW; Berger JN; Clambey ET; Lee D; Song JI; Lambert PF; Greer RO; Lee JH; Pyeon D
mBio; 2016 May; 7(3):. PubMed ID: 27143385
[TBL] [Abstract][Full Text] [Related]
14. The promoter region of interferon-gamma is hypermethylated in neonatal foals and its demethylation is associated with increased gene expression.
Sun L; Gong Z; Oberst EJ; Betancourt A; Adams AA; Horohov DW
Dev Comp Immunol; 2013 Mar; 39(3):273-8. PubMed ID: 23063468
[TBL] [Abstract][Full Text] [Related]
15. CpG methylation patterns in the IFNgamma promoter in naive T cells: variations during Th1 and Th2 differentiation and between atopics and non-atopics.
White GP; Hollams EM; Yerkovich ST; Bosco A; Holt BJ; Bassami MR; Kusel M; Sly PD; Holt PG
Pediatr Allergy Immunol; 2006 Dec; 17(8):557-64. PubMed ID: 17121582
[TBL] [Abstract][Full Text] [Related]
16. IFNG rs1861494 polymorphism is associated with IBD disease severity and functional changes in both IFNG methylation and protein secretion.
Gonsky R; Deem RL; Landers CJ; Haritunians T; Yang S; Targan SR
Inflamm Bowel Dis; 2014 Oct; 20(10):1794-801. PubMed ID: 25171510
[TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
18. Association of Ribonuclease T2 Gene Polymorphisms With Decreased Expression and Clinical Characteristics of Severity in Crohn's Disease.
Gonsky R; Fleshner P; Deem RL; Biener-Ramanujan E; Li D; Potdar AA; Bilsborough J; Yang S; McGovern DPB; Targan SR
Gastroenterology; 2017 Jul; 153(1):219-232. PubMed ID: 28400196
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin-sensitive signals control TCR/CD28-driven Ifng, Il4 and Foxp3 transcription and promoter region methylation.
Tomasoni R; Basso V; Pilipow K; Sitia G; Saccani S; Agresti A; Mietton F; Natoli G; Colombetti S; Mondino A
Eur J Immunol; 2011 Jul; 41(7):2086-96. PubMed ID: 21480212
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of
Hu Y; Xu B; He J; Shan H; Zhou G; Wang D; Bai L; Shang H; Nie L; Pan F; Lan HY; Wang Q
Front Immunol; 2023; 14():1104881. PubMed ID: 36845150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
